Hommel Lab Research
Our research focuses on improving the management of chronic conditions such as inflammatory bowel disease (IBD), eosinophil-associated gastrointestinal disorders (EGID), cystic fibrosis (CF), and functional gastrointestinal disorders (FGID). We study treatment adherence and self-management, and we systematically develop and test interventions to help patients and families better manage these conditions. We also incorporate new adherence measurement technologies into our research to assess their use and keep patients and families apprised of state-of-the-art self-management tools that may be useful to them. Our overall goal is to improve health outcomes and quality of life for the patients and families with whom we work.
We have fourteen active studies:
- 6 are randomized controlled trials of interventions to improve adherence and self-management.
- 3 are observational studies aimed at measuring treatment adherence and identifying factors related to poor outcomes.
- 2 are cross-sectional studies focused on developing and modifying a health-related quality of life (HRQoL) and disease severity measure in eosinophil esophagitis.
- 1 is field testing a newly developed HRQoL measure in FGIDs.
- 1 study allows for disclosure of previous cincinnati children's study data to the FDA.
- 1 is a large quality-improvement project in which one aim is to facilitate clinician delivery of self-management support to patients and families.
